Effect of intravitreous anti-vascular endothelial growth factor therapy on choroidal thickness in neovascular age-related macular degeneration using spectral-domain optical coherence tomography
about
Retention of good visual acuity in eyes with neovascular age-related macular degeneration and chronic refractory subfoveal subretinal fluidAnalysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography.Changes of choroidal thickness after treatment for diabetic retinopathy.Effect of anti-vascular endothelial growth factor therapy on choroidal thickness in diabetic macular edemaEvaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration.Change in choroidal thickness after intravitreal aflibercept in pretreated and treatment-naive eyes for neovascular age-related macular degeneration.Stereotactic radiotherapy in neovascular age-related macular degeneration: Real-life efficacy and morphological evaluation of the outer retina-choroid complex.Optical coherence tomography--current and future applicationsEffect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes.Subfoveal choroidal thickness changes after intravitreal bevacizumab injection for neovascular age-related macular degeneration and diabetic macular edema.Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration.Short-term choroidal thickness changes in patients treated with either ranibizumab or aflibercept: a comparative study.Oral kallidinogenase improved visual acuity and maintained chorioretinal blood flow levels after treatment for diabetic macular edema
P2860
Q33620442-9ED43C21-AF85-4E40-8BA9-4B8A34DCE8B9Q33709407-1CAE4A96-017E-4E8A-87D2-D8039DF45841Q35087325-C4EE881E-C8C8-45DD-8993-64D4CF09842CQ35647107-34B59EBF-B27C-42D0-B593-D0DD090FB3FAQ35840277-BB55508F-9F8C-4797-800B-6F7D8218055AQ35948255-24197CCB-ED03-4DC5-A4FF-0F66FDF609DBQ36209048-1215EDD6-9F92-4459-9651-1E73054D4B9EQ37552180-73FF553C-D7A4-4FD0-9BAA-65DEA5188210Q38083506-57F41BD2-A7F1-4C3D-9A0B-A2B909BAE95DQ49197963-3137D920-C33D-419E-A096-112E3BC5127DQ53611312-A31191D4-9600-4112-8BD1-59BB03EEA8A0Q53640902-38322CC5-64DB-4598-A79D-ACC2929D2ECFQ55026982-9B748E10-F422-463A-9485-790B8B1ACF60Q57071068-9F834B1D-7778-4EC5-B696-42E7AAA127F9
P2860
Effect of intravitreous anti-vascular endothelial growth factor therapy on choroidal thickness in neovascular age-related macular degeneration using spectral-domain optical coherence tomography
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effect of intravitreous anti-v ...... n optical coherence tomography
@en
Effect of intravitreous anti-v ...... optical coherence tomography.
@nl
type
label
Effect of intravitreous anti-v ...... n optical coherence tomography
@en
Effect of intravitreous anti-v ...... optical coherence tomography.
@nl
prefLabel
Effect of intravitreous anti-v ...... n optical coherence tomography
@en
Effect of intravitreous anti-v ...... optical coherence tomography.
@nl
P2093
P2860
P1433
P1476
Effect of intravitreous anti-v ...... n optical coherence tomography
@en
P2093
Caio Regatieri
Ignacio Flores-Moreno
James G Fujimoto
Jay S Duker
Lauren Branchini
Mehreen Adhi
Varsha Manjunath
P2860
P304
P356
10.1001/JAMAOPHTHALMOL.2013.692
P407
P577
2013-05-01T00:00:00Z